IPCA-AMITRIPTYLINE amitriptyline hydrohloride 25mg tablet blister pack Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

ipca-amitriptyline amitriptyline hydrohloride 25mg tablet blister pack

ipca pharma (australia) pty ltd - amitriptyline hydrochloride, quantity: 25 mg - tablet - excipient ingredients: lactose monohydrate; magnesium stearate; microcrystalline cellulose; quinoline yellow aluminium lake; macrogol 6000; purified talc; hypromellose; colloidal anhydrous silica; titanium dioxide; maize starch; crospovidone - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

IPCA-AMITRIPTYLINE amitriptyline hydrochloride 10mg tablet blister pack Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

ipca-amitriptyline amitriptyline hydrochloride 10mg tablet blister pack

ipca pharma (australia) pty ltd - amitriptyline hydrochloride, quantity: 10 mg - tablet - excipient ingredients: colloidal anhydrous silica; hypromellose; lactose monohydrate; magnesium stearate; crospovidone; macrogol 6000; titanium dioxide; maize starch; microcrystalline cellulose; purified talc; brilliant blue fcf aluminium lake - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

PIP-AMITRIPTYLINE amitriptyline hydrochloride 25mg tablet bottle pack Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

pip-amitriptyline amitriptyline hydrochloride 25mg tablet bottle pack

ipca pharma (australia) pty ltd - amitriptyline hydrochloride, quantity: 25 mg - tablet - excipient ingredients: quinoline yellow aluminium lake; purified talc; colloidal anhydrous silica; macrogol 6000; lactose monohydrate; titanium dioxide; magnesium stearate; microcrystalline cellulose; hypromellose; maize starch; crospovidone - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

AMIDEP amitriptyline hydrochloride 50mg tablet blister pack Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

amidep amitriptyline hydrochloride 50mg tablet blister pack

ipca pharma (australia) pty ltd - amitriptyline hydrochloride, quantity: 50 mg - tablet - excipient ingredients: hypromellose; crospovidone; sunset yellow fcf aluminium lake; maize starch; lactose monohydrate; purified talc; macrogol 6000; magnesium stearate; titanium dioxide; colloidal anhydrous silica; microcrystalline cellulose; indigo carmine aluminium lake - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

PPA-AMITRIPTYLINE amitriptyline hydrochloride 10mg tablet bottle pack Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

ppa-amitriptyline amitriptyline hydrochloride 10mg tablet bottle pack

ipca pharma (australia) pty ltd - amitriptyline hydrochloride, quantity: 10 mg - tablet - excipient ingredients: colloidal anhydrous silica; lactose monohydrate; crospovidone; maize starch; microcrystalline cellulose; titanium dioxide; magnesium stearate; macrogol 6000; purified talc; brilliant blue fcf aluminium lake; hypromellose - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

Pfizer (Australia) GLUCOSE INTRAVENOUS INFUSION BP 5% glucose (as monohydrate) 5g/100 mL injection for infusion vial Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

pfizer (australia) glucose intravenous infusion bp 5% glucose (as monohydrate) 5g/100 ml injection for infusion vial

pfizer australia pty ltd - glucose monohydrate, quantity: 54.99 mg/ml (equivalent: glucose, qty 50 mg/ml) - injection, intravenous infusion - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - indications as at 31 july 2000: for fluid and carbohydrate depletion wherever a non-electrolyte fluid is required. in the treatment of hypoglycaemia. in the treatment of acute diarrhoeal disease. as a vehicle for the administration of other medications.